Evidence map›Paper›PMID 41002168›Full record

ArticleJournal of the National Cancer Institute2026

Diagnostic yield of surveillance mammography among older women.

Ilana B Richman, Meghan E Lindsay, Jessica B Long, Eliza Epstein, Meera Sheffrin, Elizabeth R Berger

Abstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Surveillance mammography in older women-should we press on?Journal of the National Cancer Institute · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Ilana B RichmanSection of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.ORCID 0000-0001-7438-8907
Meghan E LindsaySection of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.ORCID 0009-0003-7004-5175
Jessica B LongSection of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.
Eliza EpsteinYale School of Medicine, New Haven, CT, United States.ORCID 0009-0003-3782-9306
Meera SheffrinSection of Geriatrics, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.ORCID 0000-0003-4003-3002
Elizabeth R BergerSection of Breast Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT, United States.ORCID 0000-0003-3857-1725

Funding

Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Lauren Ferrante · 2002 to 2026
$37.9M
Supporting Personalized Decision Making for Breast Cancer Screening among Older WomenK08CA248725 · NCI · YALE UNIVERSITY · PI RICHMAN, ILANA · 2021 to 2025
$1.3M
NCINCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032INCI NIH HHS K08 CA248725NIA NIH HHS P30 AG021342NIH HHS K08CA248725Yale Claude D. Pepper Older Americans Independence Center P30AG021342
6 · The paper itself

Abstract

backgroundMammographic surveillance is common among older women with a history of breast cancer, but little is known about imaging outcomes in this population. The goal of this study was to describe short-term outcomes after surveillance mammography among older women, including use of subsequent imaging, cancer diagnosis, and positive predictive value.

methodsThis longitudinal cohort study used Surveillance, Epidemiology and End Results-Medicare data. We followed women diagnosed with breast cancer between 2003 and 2007 at age 67 or older until diagnosis of a second primary breast cancer, death, or end of follow-up (2019). We used claims to identify surveillance mammograms. Outcomes included subsequent imaging, second primary breast cancer diagnosis, and positive predictive value after surveillance. Outcomes were identified based on proximity to surveillance mammography. We stratified analyses by age and time since diagnosis.

resultsThe cohort included 33 607 women who received 160 637 mammograms over a median of 12.1 years. Subsequent imaging was performed after 115 per 1000 mammograms (95% confidence interval [CI] = 114 to 117) and was similar across ages and time since diagnosis. Second primary breast cancer was diagnosed after 7.1 per 1000 mammograms (95% CI = 6.7 to 7.5) and was similar across ages but generally higher beginning 5 years postdiagnosis. Positive predictive value among women with subsequent imaging ranged from 3.7% to 9.2%. Most second primary breast cancers were either in situ (23.3%) or stage I (57.0%).

conclusionsAlthough surveillance mammography may detect breast cancer even years after diagnosis, surveillance also leads to substantial subsequent testing. Whether continued surveillance at older ages improves health outcomes is uncertain.

Indexed as

Breast NeoplasmsEarly Detection of CancerMammographyNeoplasms, Second PrimaryAgedAged, 80 and overFemaleHumansLongitudinal StudiesMedicarePredictive Value of TestsSEER ProgramUnited States

Identifiers

PMID41002168
PMCPMC12646037

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.